 |
|
|
Important Notice: The Forum does not endorse any medical
product or therapy. ALL medications and supplements
should be taken ONLY under the supervision of a physician,
due to the possibility of side-effects, drug interactions,
etc.
|
Drug:
|
Curcumin
|
|
Clinical Trial ID:
|
NCT00099710
|
|
Mode of action:
|
Anti-inflammation
|
|
Phase:
|
POC Completed
|
|
Company:
|
University of Western Ontario
|
|
Note:
|
Reduces oro-facial dyskinesia associated with neuroleptics
|
Bishnoi M, Chopra K, Kulkarni SK. Protective effect of
Curcumin, the active principle of turmeric (Curcuma longa)
in haloperidol-induced orofacial dyskinesia and associated
behavioural, biochemical and neurochemical changes in rat
brain. Pharmacol Biochem Behav . 2008 Feb 1 ; 88(4):511-22. Abstract
|
|
|
|
|
Text Size 
See our most recent Schizophrenia Bulletin theme Webinar: